Form 4 for MRNA Moderna
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-27 · accession 0001127602-22-016210 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-01 | 2022-05-27+ | MRNA | Hoge Stephen | Pres | M - OptEx | $34.00 | +9,841 | 1.63M | +0.6% | +$334.6K |
| DM | 2022-06-01 | 2022-05-31 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $145.02 | -8,430 | 1.63M | -0.5% | -$1.22M |
| DM | 2022-06-01 | 2022-05-27+ | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -9,841 | 16.9K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-31 | M | A | 7,431 | $0.99 | 1,632,661 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-31 | S | D | 7,431 | $144.97 | 1,624,231 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-27 | M | A | 2,410 | $135.80 | 1,625,230 | D | — | — | |
| 4 | Common | Common Stock | 2022-05-31 | S | D | 999 | $145.40 | 1,631,662 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-05-31 | M | D | 7,431 | $0.00 | 0 | D | $0.99 · — to 2023-08-19 | 7,431 Common Stock | (F6) This option is fully vested and exercisable. |
| 6 | Derivative | Restricted Stock Units | 2022-05-27 | M | D | 2,410 | $0.00 | 16,873 | D | $0.00 · 2022-02-28 to — | 2,410 Common Stock | (F5) 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter. |